|
|
|
Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease.
About meningococcal disease
Meningococcal disease can manifest as bacterial meningitis - an infection of the protective coverings of the brain and spinal cord - or meningococcemia - a bloodstream infection[2].
Novartis AG provides healthcare solutions that address the evolving needs of patients and societies.D. The remaining animals that received AEOL 10150 did not need to be sacrificed based on animal care rules, but a majority were sacrificed in order to increase the numbers that could be compared to the untreated animals sacrificed at 45 days, since there would be no untreated animals for comparison at the end of six months. In previous studies it has been shown that doses in the range of 5 to 30 mg/kg AEOL 10150 given daily starting up to 24 hrs after irradiation and administered for as long as 10 weeks mitigate functional lung injury in Fischer 344 rats. Such statements include, but are not limited to, those relating to Aeolus' product candidates, as well as its proprietary technologies and research programs.
klonopin rating xanax lorazepam compare xanax g3721 xanax pics mexican pharmacies online xanax mixing tylenol and xanax onliene pharmacies with xanax xanax federal express xanax maoi xanax to sleep
The FDA has requested additional information on the clinical and the CMC (Chemistry Manufacturing and Control) sections of the BLA. Serogroups B and C are predominant in Europe. The dynamic and unpredictable nature of meningococcal disease epidemiology warrants a vaccine that offers broad serogroup protection[6].
The foregoing release contains forward-looking statements that can be identified by terminology such as "expected," "will," "can," "dedicated," "potential," or similar expressions, or by express or implied discussions regarding potential marketing approvals for Menveo or regarding potential future revenues from Menveo.
Novartis AG provides healthcare solutions that address the evolving needs of patients and societies.] Centers for Disease Control and Prevention.gov/vaccines/pubs/pinkbook/default. Prevention and Control of Meningococcal Disease - Recommendations of the Advisory Committee on Immunization Practices.D.
“AEOL 10150 has consistently shown a protective effect against the harmful effects in radiation, including when the drug is administered up to 72 hours after exposure,” stated Zeljko Vujaskovic, M.
|
|
No News has been posted yet
|
|
|
Forgotten your password? Request a new one here.
|
 Guests Online: 1
No Members Online
Registered Members: 1
Unactivated Members: 0
Newest Member: Owen Electrical
|
|
v6.01.1 © 2003-2005